Young Healthy Nonsmokers Diagnosed with Advanced Lung Cancer
A Life Unexpectedly Changed by Cancer
Yvette Ramirez, at 32, found her world turned upside down by a diagnosis of stage 4 lung cancer, despite never smoking and lacking a family history of the disease. Living in the Netherlands, Ramirez managed her life assuming it held decades more. However, a persistent cough in 2022 brought a shocking twist.
“I have no family history and haven’t smoked, so the diagnosis was quite shocking,” Ramirez explained. Her experience highlights a worrying trend among oncologists: late-stage lung cancer in young, healthy nonsmokers.
Unexpected Symptoms in a Healthy Young Adult
Ramirez first noticed the cough after moving to the Netherlands in September 2022. She attributed it to seasonal changes. “It kept persisting for months,” she recalled. Finally, in December, her partner urged her to seek medical advice. Her general practitioner guessed bronchitis and provided typical treatment, but without success.
While visiting family in the U.S. during winter, she visited an emergency room. A chest scan showed inflammation but led to no further action. Upon returning to the Netherlands, her doctor suspected a respiratory infection. Only after these attempts did he refer her to a pulmonologist, initially suspecting tuberculosis.
A Diagnosis in the Digital Age
A PET scan changed everything. Patients in the Dutch healthcare system often receive test results online before hearing from their doctor. Ramirez opened a notification one weekend: “It said I have a tumor,” she recounted.
By February 2023, she received confirmation of stage 4 EGFR-mutated non-small cell lung adenocarcinoma. The cancer had metastasized to her brain.
A New Direction in Life
Coping with her diagnosis, Ramirez contemplated her legacy. Fueled by this motivation, she revisited a shelved project. Having grown up in a Cuban- and Salvadoran-American household, she realized a gap in children’s literature representing families like hers. Kuro Libros, her independent bilingual publishing brand, emerged with its debut title, “Mi Familia Cubana con Kuro / My Cuban Family with Kuro.”
“The book isn’t a cancer project,” Ramirez clarified. “Cancer changed my relationship with time.” Though initially hesitant to share her diagnosis, she now sees its value in highlighting the varied faces of cancer. “I wanted people to understand that stage 4 lung cancer doesn’t have just one face.”
Living Beyond a Diagnosis
Ramirez began targeted therapy with osimertinib (Tagrisso) in 2023, which she paused due to drug-related pneumonitis. Switching to erlotinib from 2024, she resumed a reduced osimertinib dose in July 2025. In March, testing revealed MET amplification, leading doctors to add tepotinib (Tepmetko) to her treatment.
Ramirez continues with consistent treatment and monitoring, describing her journey as living with a chronic disease rather than being defined by it. “Continuing plans and creating is not denial,” Ramirez said. “It’s about refusing to let cancer become my identity.”